Participants and evaluations
dyspnea
EVENTS, PATHOLOGY
A total of 135 patients were recruited. After excluding evaluations according to the criteria described above (patients without both V2 and V3 evaluations (home evaluations), signal loss greater than 10% in assessment V1, or V2 and V3; and no improvement of at least one point for dyspnea in the compensated phase), 60 patients were available for inclusion in the analyses. Figure Flow of the study participant selection process.Of the 60 patients included, all underwent the hospital evaluation (V1), but not all underwent both home evaluations (V2, V3). Therefore, not all patients included had the six observation units derived from the three planned evaluations (V1, V2, V3). In total, 93 observation units of the “change to decompensation” type (label = 1) and 159 of the “no decompensation” type (label = 0) were obtained. Figure Ox and HR time series for a patient during each evaluation of the trial. The orange and blue lines represent SpO2 and HR, respectively. The HR and SpO2 values correspond to those displayed in the left and right columns, respectively.No relevant medical events occurred during the evaluations.The baseline characteristics of the participants finally selected for model development according to the underlying pathology and the severity of the clinical picture on admission (dyspnea according to the NYHA scaleBaseline characteristics of the patients analyzed.